Trinity Capital backs Monteris Medical with $35m to scale NeuroBlate brain surgery technology
Trinity Capital Inc. provides $35 million in growth capital to Monteris Medical. Discover how the NeuroBlate system could reshape minimally invasive neurosurgery.
Savills (LSE: SVS) doubles down on investment banking with $1.1bn Eastdil Secured deal as FY25 earnings beat expectations
Savills (SVS) posts FY25 revenue of £2.55bn and agrees to acquire Eastdil Secured for $1.1bn, targeting number one position in US real estate investment banking. Read more.
M&G plc (LSE: MNG) posts record £375.9bn AUMA and £7.8bn net inflows in FY2025 as Dai-ichi partnership reshapes growth outlook
M&G plc (MNG) posts record £375.9bn AUMA, £7.8bn net inflows and a US$6bn Dai-ichi pipeline in FY2025 results. Read the full analysis.
Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
Locksley Resources (ASX: LKY) produces 99.5% purity antimony trioxide from its Mojave Project, opening a U.S. defense supply chain qualification pathway. Read the full analysis.
Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla
Lok Sabha defeats no-confidence motion against Speaker Om Birla by voice vote on 11 March 2026, the fourth such motion in Indian parliamentary history.
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
United Therapeutics reports strong Phase 3 TETON-2 results for Tyvaso in idiopathic pulmonary fibrosis. Discover why this inhaled therapy could reshape treatment.
What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption
LG CNS and Palantir expand their partnership to deploy enterprise AI across LG Group. Discover how the alliance could reshape industrial AI adoption.
The sub-1nm race is heating up and IBM and Lam Research just made their move
IBM Corporation and Lam Research Corporation launch a five-year collaboration to develop sub-1nm semiconductor technology using High-NA EUV and advanced materials. Discover what this means for the future of AI chips.
Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility
Haleon invests £65M in a Shanghai oral health plant to expand Sensodyne and parodontax across China. Discover what this move signals for the global oral care market.
GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability
Groupon (GRPN) fell 8% after Q4 revenue missed estimates and 2026 guidance trailed consensus. Read our analysis of what the miss means for the turnaround case.